FDA statement on BPA raises concerns amongst Endocrine Society experts

The Endocrine Society expresses disappointment regarding the FDA statement on BPA safety, highlighting that the CLARITY-BPA study does not examine key areas of concern. Newswise

Source: Society for Endocrinology - February 28, 2018 Category: Endocrinology Source Type: news